Next-generation sequencing (NGS) will have a dramatic impact on healthcare in the next decade. But what are the real benefits of this trend for patients, healthcare systems, and other stakeholders?
Learn more in this article, which summarizes a roundtable discussion between a panel of experts moderated by Robert Green, a medical geneticist and a physician-researcher at Mass General Brigham, the Broad Institute, Ariadne Labs, and Harvard Medical School.
The expert panel:
- Mark Gardner, Senior Vice President of Molecular Genomics and Oncology, Quest Diagnostics
- Alisa Gaskell, Director of the Precision Diagnostics Laboratory and Scientific Director, Children’s Colorado Precision Medicine Institute
- Niall Lennon, Senior Director of Translational Genomics, Broad Institute of MIT and Harvard and CSO and Chair of the Board of Managers of Broad’s Clinical Testing Laboratory
- Aleksandar Rajkovic, Chief Genomics Officer, Professor of Pathology, Medical Director, and Chief of the Center for Genetic and Genomic Medicine, University of California, San Francisco Health System
- Sean Hofherr, Chief Operating Officer and Clinical Director, Fabric Genomics
- Ryan Taft, Vice President of Scientific Research, Illumina
Image Credit: Illumina, Inc
About Illumina, Inc
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina's innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.